Tencent Music Entertainment (TME) is currently under investigation by China’s antitrust authority, according to a report in Bloomberg published August 27, citing people familiar with the matter.
According to people cited in the article, the investigation could “bring an end to exclusive licensing deals it forged with the world’s biggest record labels.” TME is majority owned by Chinese media/entertainment giant Tencent Holdings, and trades on the New York Stock Exchange.
China’s State Administration of Market Regulation launched the investigation in January this year, with the firm’s deals with Warner Music, Universal Music Group, and Sony Music Entertainment under review.
Universal, Sony, and Warner, according to the report, sold “exclusive rights to a major chunk of their music catalogues” to the music platform, which then “sub-licenses that content to smaller rivals” which they argue is anti-competitive behavior.
One of Bloomberg’s sources stated that it can “be twice as expensive” for competitors such as ByteDance or Alibaba to license music for the rest of the world from Tencent compared to licensing it direct from the labels.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile’s Acquisition of Ka’ena Corporation Receives FCC Approval
Apr 26, 2024 by
CPI
UK Regulator Announces Two New Senior Executive Appointments
Apr 26, 2024 by
CPI
Paramount Global and Skydance Media Near Merger Deal, Eyeing CEO Change
Apr 26, 2024 by
CPI
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI